Madeleine Johnson

At the ASHG meeting, early-access users compared the newly launched Naica Prism 6 to next-generation sequencing, qPCR, and other digital PCR instruments.

The system incorporates robotics from Hamilton and thermal cycling from Bio-Rad Laboratories, and is scheduled to launch early next year.

Thermo Fisher plans to expand its footprint in digital PCR, beginning with the tools space and ultimately reaching into applied markets.

As the pandemic continues to play out, test developers aren't sure how it will impact STIs and their work around developing and manufacturing tests.

Seattle-based ID Genomics is partnering with a diagnostics instrument developer to adapt its genetic fingerprinting methods for point-of-care use.

The firm is now moving forward on COVID-19 molecular diagnostic clinical trials in the US with the hopes of obtaining FDA Emergency Use Authorization.

Developed by researchers at the National Institutes of Health, the method could reduce the cost of sample prep by a factor of eight.

With a throughput of 150,000 tests per day on a single system, the workflow is now in use in a so-called megalab in the UK.

The firm received clearance and CLIA waiver for a 30-minute point-of-care PCR assay for three common STIs earlier this week.

BioFlyte has developed a system to collect pathogens from ambient air, detecting and identifying them using the FilmArray system from BioFire.